Our very own dermatologist Dr. Benjamin Barankin was quoted amongst the best dermatologists in Canada discussing new developments in psoriasis in the Oct/Nov 2014 issue of The Chronicle of Skin & Allergy. As both a busy clinician and researcher in psoriasis, Dr. Barankin’s expertise is often quoted by the media. The article highlights the existing therapies, as well as new therapies in psoriasis including generic or biosimilar biologics, anti-IL17 agents such as secukinumab, brodalumab, and ixekizumab. Scalp psoriasis and co-morbidities of psoriasis (e.g. arthritis, metabolic syndrome, diabetes, high blood pressure) are also discussed. The article also mentions the new national Canadian psoriasis guidelines of which Dr. Barankin was selected to be a part of and which will be released in 2015.